RHEUMATOID ARTHRITIS
Background
Although clinical trials have never been carried out specifically
for RA patients, the enormous amount of patient feedback
regarding the sudden disappearance of "aches and pains"
affecting various parts of their body, begged the question,
"why was this happening and how". Referencing the
various clinical studies on file, gave us the answer. To
understand
the mechanism of action, one first needs to understand what
is happening to an RA patient.
What is Rheumatoid
Arthritis?
Rheumatoid arthritis (RA) is considered a chronic, inflammatory
autoimmune disorder that causes the immune system to attack the joints.
It is a disabling and painful inflammatory condition, which
can lead to substantial loss
of mobility due to pain and joint destruction. RA is a
systemic disease, often affecting extra-articular tissues
throughout the body including
the skin, blood vessels, heart, lungs, and muscles. Autoimmune
diseases are illnesses that occur when the body tissues
are mistakenly attacked by its own immune system. The immune
system is
a complex organization
of cells and antibodies designed normally to "seek and destroy" invaders
of the body, particularly infections.
The cause of RA is still unknown,
but has long been suspected to be infectious.
It could be due to food allergies or external organisms.
As in other
autoimmune diseases, the "mistaken identity" theory suggests
that an offending organism causes an immune response that
leaves behind antibodies that are specific
to that organism. The antibodies are not specific enough,
though. They begin an immune attack because some
molecule "looks like" a molecule of the offending
organism that created the initial immune reaction - Autoimmune
diseases require that the affected individual has a defect
in the ability to distinguish foreign molecules from the body's
own.
Pharmaceutical
drug protocol
The pharmaceutical
approach is the long term management of the symptoms which
quite simply means to switch off the pain receptors or
to suppress the immune response. Long term use of these
drugs is undesirable due to the multitude of side effects.
They include the following: Painkillers, NSAID's, DMARD's,
Steroids
and Biologics.
The
Qina approach
When there
is inflammation, the immune response is to immediately
send
Macrophages (one of the key cells of the immune system)
to the infected site in order to seek and destroy the
attacking
pathogen. Among the mediators released from Macrophages,
nitric oxide (NO) is well characterized as it is toxic
to bacteria and other pathogens. However when NO is excessively
produced it directly damages normal functional tissue.
Moreover
it can also react with superoxide anion radical to form
the even stronger oxidant, peroxynitrite (ONOO-).
Therefore
by modulating the signals between the various immune
components, results in an effective regulation of (NO)
accumulation by inflammatory
stimuli. By
modulating the activated Macrophage, TNF (a cytokine
involved in systemic inflammation) and interferon, induces
a homeostatic (maintain balance or equilibrium) activity.
Conclusion:
Qina,
through a cell mediating process is able to regulate the
various components of the immune
response that is responsible for the continuous inflammatory
stimuli by regulating the excessive release of Nitric Oxide
and Peroxynitrite both of which are
capable of dismantling tissues to the point of inflicting
serious injury, resulting in reduced pain and inflammation.